These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 6085051)

  • 1. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis.
    Imperato A; Di Chiara G
    J Neurosci; 1985 Feb; 5(2):297-306. PubMed ID: 2857776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats.
    Guinetdinov RR; Bogdanov MB; Pogorelov VM; Kudrin VS; Rayevsky KS
    Neuropharmacology; 1991 Nov; 30(11):1251-4. PubMed ID: 1685561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis.
    Zetterström T; Ungerstedt U
    Eur J Pharmacol; 1984 Jan; 97(1-2):29-36. PubMed ID: 6199219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
    Kito S; Shimoyama M; Arakawa R
    Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs.
    Radhakishun FS; Korf J; Venema K; Westerink BH
    Pharm Weekbl Sci; 1983 Aug; 5(4):153-8. PubMed ID: 6622209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats].
    Bogdanov MB; Gaĭnetdinov RR; Kudrin VS; Medvedev OS; Val'dman AV
    Biull Eksp Biol Med; 1991 May; 111(5):505-7. PubMed ID: 1715214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
    Walters DE; Chapman CD; Howard SG
    J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effects of nicotine on neuroleptic-induced changes of striatal dopamine metabolism in mice.
    Haikala H
    Pharmacol Toxicol; 1989 Apr; 64(4):334-9. PubMed ID: 2568630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: a microdialysis study.
    Ståhle L; Collin AK; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):136-40. PubMed ID: 1700307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.
    Salamone JD; Keller RW; Zigmond MJ; Stricker EM
    Brain Res; 1989 May; 487(2):215-24. PubMed ID: 2786443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of extracellular DOPAC, HVA and 5-HIAA in rat striatum in vivo by differential pulse voltammetry: effect of phencyclidine, haloperidol and their coadministration.
    Crespi F; Keane PE
    Pharmacol Res Commun; 1987 Sep; 19(9):639-49. PubMed ID: 2448834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptics increase striatal catecholamine metabolites but not ascorbic acid in dialyzed perfusate.
    Blakely RD; Wages SA; Justice JB; Herndon JG; Neill DB
    Brain Res; 1984 Aug; 308(1):1-8. PubMed ID: 6206916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
    Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K
    Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine.
    Peinado J; Hameg A; Garay RP; Bayle F; Nuss P; Dib M
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):134-9. PubMed ID: 12595954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.